Osman Ilhan

48年の経験
認定:
所在地：トルコ, アンカラ
クリニック：Private Koru Ankara Hospital
Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.
続きを読む

診察

お問い合わせください

Bookimed洞察：トルコのトップCAR-T細胞療法専門家（2026）

BookimedはトルコのCAR-T細胞療法リクエスト29件を調整し、1名のトップ評価専門家と協力しています。この表の医師は国際的資格、臨床専門知識、患者の結果に基づいて選ばれています。2026年ランキングは実際の患者ケースとパートナークリニックの現行プログラムからの検証済みデータを使用して形成されています

順位	医師	経験	適合する方	特色	クリニックと所在地	診察

FAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

How do doctors in Turkey handle the logistics of CAR T-cell therapy?

Doctors in Turkey manage CAR T-cell therapy through a synchronized pipeline involving cell collection, specialized transport, and inpatient monitoring. Leading hematologists integrate international logistics with Joint Commission International (JCI) accredited facilities. They use the vein-to-vein model to maintain cell viability during engineering and re-infusion processes.

Cell collection: Specialists perform apheresis to harvest T-cells using temperature-controlled cryopreservation techniques.
Manufacturing logistics: Teams coordinate with domestic labs or international hubs to engineer patient cells.
Bridging therapy: Hematologists design temporary treatment regimens to stabilize the patient during the manufacturing period.
Post-infusion care: Patients stay in isolated bone marrow units for 14+ days to monitor progress.

Bookimed Expert Insight: Turkish specialists provide a significant clinical advantage through their extensive training at top global institutions. Dr. Osman Ilhan at Private Koru Ankara Hospital trained at MD Anderson Cancer Center. Dr. Ceyhun Bozkurt of Medical Park studied at Harvard and Cincinnati Children's. This international background allows them to manage complex cross-border cell manufacturing protocols efficiently.

Patient Consensus: Patients describe the process as a multi-step puzzle that requires staying near the hospital for several weeks. They note it is helpful to have the medical team handle shipping and customs paperwork. Many emphasize that clear communication about lab timelines and bed availability helps reduce stress during the wait.

Which medical specialties do CAR T-cell therapy doctors in Turkey hold?

CAR T-cell therapy doctors in Turkey primarily hold dual specializations in hematology and medical oncology. These experts focus on treating complex blood cancers through advanced cellular modification and bone marrow transplantation. Many specialists are internationally trained in molecular hematology and stem cell research.

Adult hematology: Physicians like Dr. Serdar Bedii Omay specialize in molecular blood disorders and transplantation.
Pediatric hematology-oncology: Experts like Dr. Ceyhun Bozkurt treat childhood leukemias using specialized cellular protocols.
Medical oncology: Specialists manage solid tumors and lymphomas while overseen by bone marrow transplant directors.
Stem cell transplantation: Doctors often lead JCI-accredited units with training from institutions like MD Anderson.

Bookimed Expert Insight: Leading Turkish specialists often hold academic leadership roles and possess extensive research backgrounds. For example, Dr. Osman Ilhan helped perform the first bone marrow transplant in Turkey. This indicates that patients receive care from pioneers who founded the country's cellular therapy associations and hold patents in hematology innovation.

Patient Consensus: Patients note that their care is guided by hematologist-oncologists while specialized transplant teams handle cell collection and infusion. Many highlight the importance of choosing centers with 24/7 inpatient monitoring to manage potential inflammatory reactions safely.

Do Turkish CAR T-cell doctors have international training or certifications?

Leading Turkish CAR T-cell therapy doctors maintain extensive international training and holds credentials from elite global medical institutions. These senior hematologists frequently complete fellowships and research tenures at centers like MD Anderson Cancer Center and Harvard University's Dana-Farber Cancer Institute.

Global training: Specialists like Dr. Osman Ilhan trained at MD Anderson and University of Genoa.
Elite affiliations: Many doctors hold active memberships in the European Society for Blood and Marrow Transplantation.
Academic leadership: Dr. Ceyhun Bozkurt conducted specialized research at Cincinnati Children's Hospital in the USA.
International research: Prof. Serdar Bedii Omay trained at Japan Mie Medical School and published 65+ articles.

Bookimed Expert Insight: Data shows that top Turkish hematologists often hold leadership roles in global regulatory bodies. For example, Dr. Osman Ilhan served as President of the Turkish Hematology Association and received a Platinum CME certificate from the European Hematology Association. This indicates that Turkish specialists are not just followers of global protocols but active contributors to international cellular therapy standards.

Patient Consensus: Patients note that while international degrees are impressive, the team's ability to manage treatment side effects is what truly matters. They emphasize checking if the hospital has a dedicated ICU and pharmacy support for complex cell therapies. Many feel more confident when the medical team has managed numerous cases and follows recognized CAR T pathways.

Who are the leading doctors offering adult CAR T-cell therapy in Turkey?

Leading specialists in Turkey for adult CAR T-cell therapy hold extensive backgrounds in hematology and stem cell transplantation. These experts typically practice at JCI-accredited facilities in Istanbul and Ankara. They possess specialized training from top international institutions and lead dedicated cellular immunotherapy programs for blood cancers.

Dr. Osman Ilhan: Pioneer who performed Turkey's first stem cell transplant with MD Anderson training.
Dr. Serdar Bedii Omay: Specialist in molecular hematology with doctoral training from Mie Medical School in Japan.
Dr. Bulent Eser: Member of the European Group for Blood and Marrow Transplantation at Medical Park.
Dr. Sarah Sirinoglu Temiz: Expert in therapeutic apheresis who previously managed specialized stem cell transplantation units.

Bookimed Expert Insight: Data shows that top hematologists in Turkey often hold cross-continental credentials. Dr. Serdar Bedii Omay and Dr. Osman Ilhan possess specific training from Japan, Italy, and the USA. This international exposure is vital for CAR T-cell therapy. It ensures they stay updated on global protocols for managing complex side effects like cytokine release syndrome.

Patient Consensus: Patients emphasize selecting centers that manage the entire cellular manufacturing process on-site. Realizing that the team has experience with specific post-infusion side effects like confusion or fever provides peace of mind. Many note that having coordinators handle the long six-week monitoring period makes the complex logistics manageable.

Who are the top pediatric CAR T-cell therapy doctors in Turkey?

Top pediatric CAR T-cell therapy doctors in Turkey include Dr. Ceyhun Bozkurt and Dr. Hilmi Apak. These experts lead dedicated units with training from Cincinnati Children's and Harvard's Dana-Farber. They specialize in treating childhood leukemia and lymphoma using advanced cellular protocols and JCI-accredited laboratory infrastructure.

Dr. Ceyhun Bozkurt: Director at Medical Park Bahcelievler with fellowship training at Cincinnati Children's Hospital.
Dr. Hilmi Apak: Heads the pediatric division at Biruni University with over 75 international publications.
Dr. Birol Baytan: Specialist at Emsey Hospital with 20+ years of experience in childhood blood disorders.
Center expertise: Medical Park and Biruni University provide specialized intensive care for managing pediatric complications.

Bookimed Expert Insight: Data shows that top Turkish specialists like Dr. Osman Ilhan and Dr. Ceyhun Bozkurt are not just clinicians but pioneers who established the nation's stem cell banks. Dr. Ilhan performed Turkey's first bone marrow transplant and holds over 300 PubMed-indexed publications. This academic leadership ensures that pediatric protocols in Istanbul follow the latest international cellular therapy guidelines.

Patient Consensus: Parents emphasize that the hospital's intensive care protocols are as important as the doctor's name. They often notice that coordination between the stem cell unit and ICU teams is vital for managing side effects. Families feel more at ease when physicians provide clear timelines for the infusion and recovery process.

How much hands-on procedural experience do Turkish CAR T-cell doctors typically have?

Turkish CAR T-cell doctors possess extensive hands-on experience by leveraging decades of bone marrow transplantation expertise. Leading specialists often have over 30 to 45 years of clinical practice. They have performed over 900 cellular procedures, adapting these skills to manage cell harvesting and immunotherapy complex reactions.

Transplant-led foundation: Experts like Dr. Osman Ilhan pioneered Turkey's first bone marrow stem-cell transplants.
International fellowship training: Surgeons trained at prestigious centers like MD Anderson and Harvard University.
Dual-specialty mastery: Practitioners often hold dual certifications in internal medicine and hematology or oncology.
High procedural volume: Senior clinicians at Emsey Hospital have 40+ years of progressive academic experience.

Bookimed Expert Insight: Data suggests a pattern where Turkey's top experts are not just clinicians but founders of national cellular therapy societies. For instance, Dr. Osman Ilhan at Private Koru Ankara Hospital holds four medical patents. This academic leadership indicates that patients receive care from doctors who literally wrote the national protocols for cell handling and apheresis.

Patient Consensus: Patients note that their confidence grew when they saw the entire team working together. They felt safer knowing the clinics had 24/7 ICU support and dedicated coordinators to manage side effects like cytokine release. Most patients were relieved to find specialists who were used to high-risk inpatient care.

How do Turkish doctors manage the in-house production and timing of CAR T-cells?

Turkish doctors manage CAR T-cell production through point-of-care manufacturing at Good Manufacturing Practice (GMP) certified facilities. This decentralized approach eliminates overseas shipping and optimizes the vein-to-vein timeline. Highly qualified hematologists use chemical inhibitors like BX-795 to accelerate gene delivery and cell expansion processes.

Technical acceleration: Doctors use the BX-795 inhibitor to block antiviral signaling in T-cells.
Optimized timing: Local production reduces the manufacturing window to just 9 to 12 days.
Fresh infusion: In-house manufacturing avoids cryopreservation to maintain maximum cellular potency and survival.
Adaptive protocols: Clinicians coordinate bridging therapy on-site to stabilize the patient during cell growth.

Bookimed Expert Insight: Data shows that top Turkish specialists like Dr. Osman Ilhan at Private Koru Ankara Hospital and Dr. Serdar Bedii Omay at Emsey Hospital integrate molecular hematology with extensive apheresis experience. This dual expertise is vital because it allows centers to manage both the industrial manufacturing of cells and the immediate clinical needs of the patient under one roof.

Patient Consensus: Patients note that a smooth pipeline between cell collection and infusion is essential to reduce anxiety. They appreciate when a center provides a clear turnaround time before the process starts. Many were surprised that the process feels like an industrial sequence where scheduling discipline is just as important as medical care.

Can international patients easily communicate with CAR T-cell doctors in Turkey?

International patients communicate effectively with CAR T-cell doctors in Turkey through structured support systems and multilingual medical staff. Leading hematologists often hold international fellowships from institutions like Harvard or MD Anderson. Hospitals provide dedicated coordinators and native-speaking interpreters to manage every step of the complex oncology journey.

Specialized coordinators: Dedicated staff manage logistics from initial scan reviews to post-infusion follow-up.
Multilingual expertise: Doctors like Dr. Rafet Eren are fluent in English for direct communication.
International training: Many professors completed training in the USA, Japan, or Europe.
Written documentation: Medical teams provide translated instructions for after-care and medication management.

Bookimed Expert Insight: Data shows that Turkey's cellular therapy leaders, such as Dr. Osman Ilhan and Dr. Ceyhun Bozkurt, often lead dedicated stem cell units. These experts frequently serve as presidents of national hematology associations. This dual role means they oversee both the clinical treatment and the specialized lab teams. Patients benefit from this integrated oversight during the apheresis and infusion stages.

Patient Consensus: Patients note that having a single translator throughout the multi-week hospital stay makes the process much easier. They emphasize the value of using WhatsApp for quick updates between physician rounds. Many find that receiving written summaries of side effects helps them feel more prepared for recovery.

アンカラで最高のCAR-T細胞療法医師 - トップ1名の医師

トルコの3名のトップCAR-T細胞療法専門家から見積もりを取得

医師サービスで最良価格の国を選択